These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30509446)

  • 1. Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studies.
    Lories RJ; Haroon N
    Best Pract Res Clin Rheumatol; 2017 Dec; 31(6):877-886. PubMed ID: 30509446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone formation in axial spondyloarthritis.
    Lories RJ; Haroon N
    Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):765-77. PubMed ID: 25488783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms, impact and prevention of pathological bone regeneration in spondyloarthritis.
    Neerinckx B; Lories R
    Curr Opin Rheumatol; 2017 Jul; 29(4):287-292. PubMed ID: 28376064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Disease in Axial Spondyloarthritis.
    Van Mechelen M; Gulino GR; de Vlam K; Lories R
    Calcif Tissue Int; 2018 May; 102(5):547-558. PubMed ID: 29090349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of new bone formation and ankylosis in spondyloarthritis.
    Lories RJ; Schett G
    Rheum Dis Clin North Am; 2012 Aug; 38(3):555-67. PubMed ID: 23083755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?
    Neerinckx B; Lories RJ
    Curr Rheumatol Rep; 2017 Mar; 19(3):14. PubMed ID: 28265849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Paradox of Bone Formation and Bone Loss in Ankylosing Spondylitis: Evolving New Concepts of Bone Formation and Future Trends in Management.
    Magrey MN; Khan MA
    Curr Rheumatol Rep; 2017 Apr; 19(4):17. PubMed ID: 28361330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we stop progression of ankylosing spondylitis?
    Schett G; Rudwaleit M
    Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):363-71. PubMed ID: 20534370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Might axial myofascial properties and biomechanical mechanisms be relevant to ankylosing spondylitis and axial spondyloarthritis?
    Masi AT
    Arthritis Res Ther; 2014; 16(2):107. PubMed ID: 25166000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in understanding the pathophysiology of spondyloarthritis.
    Lories RJ
    Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):331-341. PubMed ID: 31171306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat metaplasia and backfill are key intermediaries in the development of sacroiliac joint ankylosis in patients with ankylosing spondylitis.
    Maksymowych WP; Wichuk S; Chiowchanwisawakit P; Lambert RG; Pedersen SJ
    Arthritis Rheumatol; 2014 Nov; 66(11):2958-67. PubMed ID: 25047851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes.
    Tseng HW; Pitt ME; Glant TT; McRae AF; Kenna TJ; Brown MA; Pettit AR; Thomas GP
    Arthritis Res Ther; 2016 Jan; 18():35. PubMed ID: 26831337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis: a paradox in ankylosing spondylitis.
    Carter S; Lories RJ
    Curr Osteoporos Rep; 2011 Sep; 9(3):112-5. PubMed ID: 21647573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
    Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
    Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are current available therapies disease-modifying in spondyloarthritis?
    Lories RJ; de Vlam K; Luyten FP
    Best Pract Res Clin Rheumatol; 2010 Oct; 24(5):625-35. PubMed ID: 21035084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of bone morphogenetic proteins in ankylosing spondylitis.
    Carter S; Braem K; Lories RJ
    Ther Adv Musculoskelet Dis; 2012 Aug; 4(4):293-9. PubMed ID: 22859928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models.
    Braem K; Lories RJ
    Joint Bone Spine; 2012 May; 79(3):243-8. PubMed ID: 22079413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular biology of new bone formation: insights into the ankylosis of ankylosing spondylitis.
    Zhang X; Aubin JE; Inman RD
    Curr Opin Rheumatol; 2003 Jul; 15(4):387-93. PubMed ID: 12819465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ankylosis in ankylosing spondylitis: current concepts.
    Haroon N
    Clin Rheumatol; 2015 Jun; 34(6):1003-7. PubMed ID: 25935456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort.
    Chung HY; Machado P; van der Heijde D; D'Agostino MA; Dougados M
    Ann Rheum Dis; 2012 Jun; 71(6):809-16. PubMed ID: 21989541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.